theglobeandmail.com
Positivewww.theglobeandmail.com ·
article prescribeit canada health infoway 400000 executive travel three years
EPU_CATS_HEALTHCAREWB_2024_ANTI_CORRUPTION_AUTHORITIESWB_840_JUSTICEWB_2025_INVESTIGATION
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article details mismanagement and low adoption of a government-funded digital prescription program in Canada. The commercial mechanism is weak: no direct impact on product prices, supply chains, or company margins. The primary effect is reputational and regulatory risk for the non-profit and its contractors (Telus Health, Accenture, Deloitte). No scarcity or price signal is generated.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Canada Health Infoway spent over $400,000 on executive travel in less than three years.
- The PrescribeIT program received more than $298 million in federal funding.
- Less than 5% of prescriptions are processed through PrescribeIT.
- Former CEO Michael Green accounted for over $147,000 of travel expenses and earned nearly $900,000 annually.
- The House of Commons health committee is investigating the organization.